Exercise Program for Blood Cancer Fatigue
Part of Blood & lymphatic, Cancer clinical trials.
This study tests whether a personalized exercise program can reduce fatigue in patients with certain blood cancers (myeloproliferative neoplasms or chronic myeloid leukemia). The program is supervised and designed to help you regain energy and improve your quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with polycythemia vera, essential thrombocythemia, primary myelofibrosis, or chronic myeloid leukemia
- Your cancer has been stable on current treatment for at least 8 weeks
- You experience significant fatigue related to your blood cancer
- You have not done structured exercise or rehabilitation in the past 3 months
- Your blood counts meet minimum safety levels (hemoglobin above 10 and platelets above 100,000)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help people who have survived a blood cancer stay healthier as they age. It involves exercise and check-ups to see if we can slow down some effects of aging.
This trial tests a personalized supportive care program that combines exercise, nutrition, and coaching to help reduce fatigue in people with certain slow-growing lymphomas. It aims to improve energy and quality of life.
This trial tests whether exercise is safe and feasible for people with low-risk myeloid cancers or certain bone marrow conditions. It aims to see if a supervised exercise program can be done without problems.
This study tests whether a regular exercise program can improve health and well-being for people with myeloproliferative neoplasms (a group of blood cancers). It is designed to help you feel stronger and manage your condition better.
This study tests a personalized exercise program for people with certain cancers (lung, colorectal, breast, CLL, or multiple myeloma) who are on specific treatments. The goal is to see if tailored physical activity improves your health and well-being during cancer care.
This trial tests if an exercise program using a wearable device can help reduce fatigue and improve quality of life in teenagers with cancer who are currently on treatment. It might be a good fit if you are between 13 and 18 years old, are getting chemotherapy, and are feeling well enough to do light exercise.
Hear when a new Myeloproliferative Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.